High-dose-rate versus low-dose-rate monotherapy in the treatment of localized prostate cancer:
The case for high-dose-rate monotherapy: An up and coming treatment option for low-risk prostate cancer
To access this article, please choose from the options below
PII: S1538-4721(06)00003-1
doi:10.1016/j.brachy.2006.01.001
© 2006 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
